Trial Profile
PROtection of coronary Microcirculation by Iloprost: Safety and Efficacy evaluation in PCI.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Jul 2011
Price :
$35
*
At a glance
- Drugs Iloprost (Primary)
- Indications Coronary artery disease
- Focus Adverse reactions; Therapeutic Use
- Acronyms PROMISE
- 08 Jul 2011 New trial record